Impact of polyethylene glycol polymer source variations on the performance of long-acting injectable suspensions
International Journal of Pharmaceutical Excipients · 2026
DOI: 10.66617/001c.171808 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Excipients, 2026. Verfasst von Nilesh Malavia und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Long-acting injectable (LAI) suspensions rely on polymeric excipients such as polyethylene glycol (PEG) to stabilize suspended drug particles and modulate release behavior. While generic LAI formulations must be compositionally equivalent (Q1/Q2) to their reference listed drug, excipients sourced from different manufacturers may exhibit subtle but functionally significant differences in physicochemical properties. This study investigated the impact of PEG3350 source variability on the physicochemical properties and in vitro performance of medroxyprogesterone acetate (MPA) suspensions equivalent to Depo-Provera®. PEG3350 polymers obtained from four commercial sources.
Zitieren
APA
Malavia, N., Badole, S., Sabatella, M., Bao, Q., & Burgess, D. J. (2026). Impact of polyethylene glycol polymer source variations on the performance of long-acting injectable suspensions. International Journal of Pharmaceutical Excipients. https://doi.org/10.66617/001c.171808
Vancouver
Malavia N, Badole S, Sabatella M, Bao Q, Burgess DJ. Impact of polyethylene glycol polymer source variations on the performance of long-acting injectable suspensions. International Journal of Pharmaceutical Excipients. 2026. doi:10.66617/001c.171808
BibTeX
@article{Malavia2026,
author = {Malavia, Nilesh and Badole, Saurabh and Sabatella, Melissa and Bao, Quanying and Burgess, Diane J.},
title = {Impact of polyethylene glycol polymer source variations on the performance of long-acting injectable suspensions},
journal = {International Journal of Pharmaceutical Excipients},
year = {2026},
doi = {10.66617/001c.171808}
}
EUVIMED